http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005137256-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202 |
| filingDate | 2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_387c4c84e32a5cd2e8c799372fcbeffb |
| publicationDate | 2005-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2005137256-A1 |
| titleOfInvention | Use of arachidonic acid as a method of increasing skeletal muscle mass |
| abstract | This invention discloses a method of orally administering arachidonic acid and its derivatives for the purpose of increasing the serum level of the prostaglandin PGF2alpha and subsequently the level of retained skeletal muscle mass. |
| priorityDate | 2002-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 121.